Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Rheumatoid Arthritis (RA)”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Large-scale testing (Phase 3)Ended earlyNCT01410695
What this trial is testing

Masitinib in Refractory Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)
AB Science 324
Testing effectiveness (Phase 2)Study completedNCT01274182
What this trial is testing

GP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard Therapy

Who this might be right for
Rheumatoid Arthritis
Sandoz 312
Early research (Phase 1)Looking for participantsNCT06978647
What this trial is testing

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Inflammatory Myopathy+5 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 12
Early research (Phase 1)Looking for participantsNCT07115745
What this trial is testing

Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

Who this might be right for
Refractory Autoimmune Diseases
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 125
Early research (Phase 1)Looking for participantsNCT07085676
What this trial is testing

Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Idiopathic Inflammatory Myopathy (IIM)+1 more
Polina Stepensky 60
Very early researchNot Yet RecruitingNCT06982547
What this trial is testing

Clinical Study on the Treatment of Refractory Rheumatoid Arthritis With UTAA91 Injection

Who this might be right for
Rheumatoid Arthritis (RA)
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 24
Early research (Phase 1)Looking for participantsNCT07100873
What this trial is testing

ADI-001 in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)
Adicet Therapeutics 25
Testing effectiveness (Phase 2)Looking for participantsNCT06991114
What this trial is testing

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Who this might be right for
Refractory Rheumatoid Arthritis (RA)Idiopathic Inflammatory Myopathies (IIMs)Systemic Sclerosis (SSc)+6 more
Artiva Biotherapeutics, Inc. 90
Very early researchLooking for participantsNCT07001956
What this trial is testing

The Clinical Study on the Treatment of Refractory RA With UTAA91 Injection

Who this might be right for
Rheumatoid Arthritis (RA)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 24
Large-scale testing (Phase 3)Active Not RecruitingNCT04539964
What this trial is testing

Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
SetPoint Medical Corporation 243
Post-approval studies (Phase 4)Study completedNCT01715831
What this trial is testing

A Long-term Safety Extension Study of Tocilizumab in Brazilian Participants With Rheumatoid Arthritis (RA) Who Completed the Studies ML21530 and MA21488

Who this might be right for
Arthritis, Rheumatoid
Hoffmann-La Roche 26
Very early researchLooking for participantsNCT06888960
What this trial is testing

Safety Study of CC312 in Autoimmune Disease Patients

Who this might be right for
Systemic Lupus Erythematosus (SLE)Idiopathic Inflammatory Myopathy (IIM)Systemic Sclerosis (SSc)+3 more
CytoCares Inc 18
Not applicableLooking for participantsNCT07163221
What this trial is testing

At-home Ultrasound Localized Therapy for Rheumatoid Arthritis Study [At-home ULTRA Study]

Who this might be right for
Rheumatoid Arthritis (RA)
SecondWave Systems Inc. 60
Post-approval studies (Phase 4)Not Yet RecruitingNCT07008196
What this trial is testing

Telitacicept for the Treatment of Refractory RA

Who this might be right for
Rheumatoid Arthritis (RA)
Chinese SLE Treatment And Research Group 30
Testing effectiveness (Phase 2)Study completedNCT05460832
What this trial is testing

Phase 2b Study of MBS2320 in Participants With Methotrexate-Refractory RA

Who this might be right for
Rheumatoid Arthritis
Modern Biosciences Ltd 248
Testing effectiveness (Phase 2)Study completedNCT01663116
What this trial is testing

Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis Aggravated
Tigenix S.A.U. 53
Not applicableLooking for participantsNCT07403188
What this trial is testing

A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101

Who this might be right for
Refractory Lupus NephritisMyasthaenia GravisStiff Person Syndrome+4 more
Kyverna Therapeutics 70
Testing effectiveness (Phase 2)Looking for participantsNCT07048197
What this trial is testing

Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis and Sjogren's Disease

Who this might be right for
Rheumatoid Arthritis (RA) and Sjögren's Disease (SjD)
Novartis Pharmaceuticals 27
Early research (Phase 1)Looking for participantsNCT06946199
What this trial is testing

An Open-label Study of Cizutamig in Refractory Seropositive Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 28
Early research (Phase 1)Looking for participantsNCT06994143
What this trial is testing

CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA
Cullinan Therapeutics Inc. 37